| Literature DB >> 25583298 |
Helen Legrand1, Mats Pihlsgård, Eva Nordell, Sölve Elmståhl.
Abstract
BACKGROUND: Few studies on fall risk factors use long-recommended methods for analysis of recurrent events. Previous falls are the biggest risk factor for future falls, but few fall studies focus on the youngest-old. AIMS: This study's objective was to apply Cox regression for recurrent events to identify factors associated with injurious falls in the youngest-old.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25583298 PMCID: PMC4513192 DOI: 10.1007/s40520-014-0308-x
Source DB: PubMed Journal: Aging Clin Exp Res ISSN: 1594-0667 Impact factor: 3.636
Covariate composition and data collection methods
| Covariate | Sub-variables | Data collection method |
|---|---|---|
| Ischemic heart disease | Angina, myocardial infarction, percutaneous coronary intervention, coronary surgery, congestive heart failure | From history (including patient chart) or by physical examination for congestive heart failure |
| Cerebral hypoperfusion | Arrhythmia, symptoms or signs of orthostatic hypotension | From patient history (including patient chart), self-report of orthostatic hypotension symptoms in the past year, and signs or symptoms during orthostasis testing in clinic |
| CNS disease | Cerebral infarct, transient ischemic attack, RIND, intracranial hemorrhage, Parkinson disease, epilepsy, multiple sclerosis | From history (including patient chart) |
| Psychiatric disorder | Dementia, depression, psychosis, sleep disturbances, anxiety | From history (including patient chart) |
| Sensory impairment | Blindness in one or both eyes, unable to read J4 or larger text on Jaeger chart, subjective vision impairment, tinnitus, hearing impairment on exam, subjective hearing impairment, deafness | From history (including patient chart), patient self-report in questionnaires, and physical exam (including whisper test and Jaeger chart exam with patient’s own visual aids) |
| Cancer in past 10 years | Inpatient diagnosis code for cancer in the past 10 years | Solely from National diagnosis registry |
| Obstructive lung disease | Chronic obstructive lung disease, asthma with current treatment | From history (including patient chart) |
| Musculoskeletal disease | Pain on movement; osteoarthritis of back, hip, knee, or toes; inflammatory arthritis; ankylosing spondylitis; polymyalgia rheumatica | From history (including patient chart) |
| Dizziness and balance disorders | Subjective feeling of dizziness, subjective tendency to fall, subjective feeling of balance problem, unable to complete 60 s balancing on one leg (right or left) with eyes open, Ménières disease | From patient self-report questionnaires, history (including patient chart), and physical exam (one-leg standing test with patient barefoot, without balance aids, and arms hanging by sides) |
| Diabetes | Type I or II | From history (including patient chart) |
| Head trauma | With or without loss of consciousness | from history (including patient chart) |
| Substance abuse | Self-report | From history |
| Walking speed below age group median | Maximal or self-selected walking speed below age group median | Walking timed from time subject crosses first marked point on floor, reaches second marked point 15 meters further, turns 180 degrees and walks 15 meters back. Two extra meters provided to start and slow down before and after marked distance. Measured both for self-selected and maximal walking speed. Normal shoes and walking aids allowed |
| Nervous system medication | Benzodiazepines (ATC classes N03AE, N05BA, N05CD), neuroleptics (ATC class N05A), sedative/hypnotics (ATC class N05C), anticholinergics (ATC class N04A), antidepressants (N06A) | Patient taking any of these medication classes at time of study visit from history (including patient chart) |
| Antihypertensive medication | ATC class C02, Diuretics (ATC class C03), beta-blockers (ATC class C07), ACE inhibitors and angiotensin receptor blockers (ATC class C09), calcium channel blockers (ATC class C08) | Patient taking any of these medication classes at time of study visit from history (including patient chart) |
| Opiate medication | ATC class N02A | Patient taking any of these medication classes at time of study visit from history (including patient chart) |
Baseline exposure to covariates in 1,382 youngest-old individuals
| Covariate | Exposed | Missing |
|---|---|---|
| Ischemic heart disease | 159 (13.6) | 11 (0.9) |
| Cerebral hypoperfusion | 369 (31.5) | 26 (2.2) |
| CNS disease | 58 (4.9) | 6 (0.5) |
| Psychiatric disorder | 550 (46.9) | 14 (1.2) |
| Sensory impairment | 619 (52.8) | 36 (3.1) |
| Cancer in past 10 yearsa | 71 (6.1) | – |
| Obstructive lung disease | 79 (6.7) | 12 (1.0) |
| Musculoskeletal disease | 769 (65.6) | 6 (0.5) |
| Dizziness and balance disorders | 810 (69.1) | 7 (0.6) |
| Diabetes | 88 (7.5) | 5 (0.4) |
| Head trauma | 209 (17.8) | 14 (1.2) |
| Substance abuse | 62 (5.3) | 6 (0.5) |
| Walking speed below age group median; self-selected or maximum | 23 (2.0) | |
| At either self-selected or maximum | 264 (22.5) | |
| At both self-selected and maximum | 426 (36.3) | |
| Nervous system medicationb | 170 (14.5) | – |
| Antihypertensive medicationb | 326 (27.8) | – |
| Opiate medicationb | 62 (5.3) | – |
aVariables from registry that is in theory complete for all participants
bData from medical records and patient interviews that are in theory complete for all participants
Time to event Cox regression for injurious falls based on fall risk covariates in 1,133 youngest-old individuals
| Covariate |
| Hazard ratio | (95 % CI) |
|---|---|---|---|
| Male sex | 0.05 | 0.78 | (0.61–1.00) |
| Nervous system medication | 0.03 | 1.40 | (1.03–1.89) |
| CNS disease | 0.006 | 1.79 | (1.18–2.70) |
| Psychiatric disorder | 0.23 | 1.17 | (0.91–1.51) |
| Musculoskeletal disease | 0.20 | 1.19 | (0.91–1.55) |
| Dizziness and balance disorders | 0.19 | 1.21 | (0.91–1.61) |
| Walking speed below age group median; self-selected or maximum | |||
| At either self-selected or maximum | 0.92 | 1.02 | (0.74–1.40) |
| At both self-selected or maximum | 0.41 | 1.13 | (0.85–1.50) |
| Previous fall | <0.001 | 2.00 | (1.50–2.68) |